Adaptimmune Therapeutics plc Free Cash Flow Generation Index

Latest as of June 2024: 0.98x

Adaptimmune Therapeutics plc free cash flow generation index. Adaptimmune Therapeutics plc (473A) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of €46.65 Million represents 1% of operating cash flow (€47.40 Million).

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

€46.65 Million
EUR

Operating Cash Flow

€47.40 Million
EUR

Capital Expenditures

€754.00K
EUR

Free Cash Flow Generation Index of Adaptimmune Therapeutics plc (2021–2021)

Free cash flow generation index of Adaptimmune Therapeutics plc from 2021 to 2021. Historical FCF Generation Index trend for Adaptimmune Therapeutics plc across 1 annual periods. See 473A financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Adaptimmune Therapeutics plc Free Cash Flow Generation Index by Year (2021–2021)

Adaptimmune Therapeutics plc free cash flow generation index by year from 2021 to 2021. Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics plc (473A) cash conversion ratio.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2021 0.18x €1.95 Million €10.73 Million €8.57 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).